Jun. 21 at 3:35 PM
5 dirt-cheap names with real upside potential if the re-rating kicks in.
$EXPE
Strong ROE/ROIC profile with a net cash balance sheet. Trading ~12x forward EPS with sub-1% yield, low payout-still a cash-generating travel engine.
$FDS
High-quality data business. ~27 straight years of dividend growth, ~12x EPS, solid margins, and sticky institutional demand. Quiet compounder.
$FHI
Asset manager with strong capital efficiency and net cash structure. ~11.5x EPS, disciplined payout ratio, consistent shareholder returns.
$ZTS
Animal health leader with premium margins and durable demand. ~11x EPS with steady dividend growth track record. Defensive compounder.
$BAH
Defense + consulting hybrid. Low multiple (~10x EPS) with steady cash flow and consistent dividend hikes. Government demand adds stability.
What stands out here isn’t hype-it’s pricing. Quality balance sheets + low multiples + dividend discipline. Market is still underpricing cash-flow durability in these names.
